Graphite Bio Inc

NASDAQ:GRPH  
24.30
-0.69 (-2.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Graphite Bio Inc Stock, NASDAQ:GRPH

279 East Grand Avenue, Suite 430, South San Francisco, California 94080
United States of America
Phone: +1.650.484.0886
Number of Employees:
http://www.graphitebio.com

Description

Graphite Bio, Inc. operates as a clinical-stage gene editing company. It focuses on therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo in June 2017 and is headquartered in South San Francisco, CA.